Skip to content
value.today

WindMIL Therapeutics, Inc.

🇺🇸 Princeton, New Jersey, USABiotechnologyFounded 2015
Total raised
$45 M
3 rounds on record
Latest round
$2 M
Jan 2021
First round on record
Mar 2016
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of WindMIL Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2021$2 MNo. 3$2 to $10 million

WindMIL Therapeutics, Inc.: Raise no. 3, Jan 2021

Investors in this round

11 investors had bought by the notice of Feb 5, 2021: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $5 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Donald J. Hayden, Jr. · Executive Officer, Director
  • Patrick J. Fabbio · Executive Officer
  • Anna J. French · Director
  • Brian J. Dovey · Director
  • Daniel J. O'Donnell · Director
  • Howard J. Soule · Director
  • Mark J. McDade · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount of $5,000,000 will be sold in two tranches. The first tranche equal to $2,334,814.78 of the total offering amount was sold on January 26, 2021. The remaining tranche will be sold upon the occurrence of certain events.”

Signed by Donald J. Hayden, Jr., Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 5, 2021. Read the notice at the SEC.

debt, optionsSEC
Jun 2018$33 MNo. 2$10 to $50 million

WindMIL Therapeutics, Inc.: Raise no. 2, Jun 2018

Investors in this round

11 investors had bought by the notice of Jun 15, 2018: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$33 M of $33 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Halak · Executive Officer, Director
  • Allan Fox · Director
  • Brian Dovey · Director
  • Donald Hayden, Jr. · Director
  • Howard Soule · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Halak, Ceo. Source: SEC Form D, newest notice filed Jun 15, 2018. Read the notice at the SEC.

equitySEC
Mar 2016$10 MNo. 1$10 to $50 million

WindMIL Therapeutics, Inc.: Raise no. 1, Mar 2016

Investors in this round

4 investors had bought by the notice of Apr 7, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Brian Halak · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Brian Halak, President. Source: SEC Form D, newest notice filed Apr 7, 2016. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • WindMIL Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2021).

    SEC Form D · Feb 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Feb 2021

That is all the official record says: WindMIL Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of WindMIL Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by WindMIL Therapeutics, Inc.
NameRoleNamed in
Donald J. Hayden, Jr.Executive officerFeb 2021
Patrick J. FabbioExecutive officerFeb 2021
Brian HalakExecutive officerJun 2018
Anna J. FrenchDirectorFeb 2021
Brian J. DoveyDirectorFeb 2021
Daniel J. O'DonnellDirectorFeb 2021
Donald J. Hayden, Jr.DirectorFeb 2021
Howard J. SouleDirectorFeb 2021
Mark J. McDadeDirectorFeb 2021
Allan FoxDirectorJun 2018
Brian DoveyDirectorJun 2018
Brian HalakDirectorJun 2018
Donald Hayden, Jr.DirectorJun 2018
Howard SouleDirectorJun 2018